Vicarious Surgical RBOT
OTC RBOT
$0.04 -0.01 (-17.05%)
At close: Aug 19, 2026 · 3:39 PM UTC

Vicarious Surgical (RBOT) Total Debt (2021 - 2022)

Vicarious Surgical (RBOT) posted quarterly Total Debt of $250000.0 for Q3 2022, down 70.1% year-over-year from $836000.0 in Q3 2021, and down 36.22% quarter-over-quarter from $392000.0 in Q2 2022.

Vicarious Surgical (RBOT) Total Debt (2021 - 2022) Analysis & Trends

Vicarious Surgical (RBOT) has reported Total Debt for 2 consecutive years, with $250000.0 the latest figure, recorded in Q3 2022.

  • In Q3 2022, Total Debt fell 70.1% year-over-year to $250000.0; the TTM figure through Sep 2022 stood at $250000.0 (down 70.1% YoY), while the FY2021 annual figure was $675000.0, changed N/A from the prior year.
  • Total Debt slipped to $250000.0 in Q3 2022 per RBOT's latest filing, from $392000.0 in the prior quarter.
  • Across five years, Total Debt topped out at $836000.0 in Q3 2021 and bottomed at $250000.0 in Q3 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Abbott Laboratories 199.61 Bn 194.01 Bn 7.27 Bn 32.61 Bn
2 Stryker 127.81 Bn 124.34 Bn 4.50 Bn 14.94 Bn
3 Medtronic 119.04 Bn 109.82 Bn 6.41 Bn 27.96 Bn
4 Boston Scientific 73.68 Bn 73.14 Bn 3.85 Bn 12.62 Bn
5 Edwards Lifesciences 51.96 Bn 47.71 Bn 1.35 Bn 598.70 Mn
6 Dexcom 34.36 Bn 32.41 Bn 830.00 Mn -
7 GE HealthCare Technologies 33.83 Bn 31.72 Bn 2.18 Bn 10.10 Bn
8 Koninklijke Philips 26.36 Bn 23.04 Bn 4.55 Bn 8.68 Bn
9 Steris 23.06 Bn 22.58 Bn 684.20 Mn 1.89 Bn
10 Vicarious Surgical 196,495.36 -14.84 Mn - -

Historic Data

Download Data
DateValue
Sep 30, 2022 250,000.00
Jun 30, 2022 392,000.00
Mar 31, 2022 534,000.00
Dec 31, 2021 675,000.00
Sep 30, 2021 836,000.00